Ms Shao-ti Liu Meredith, ARNP | |
8299 161st Ave Ne, Suite 101, Redmond, WA 98052-3860 | |
(425) 881-8813 | |
(425) 869-7201 |
Full Name | Ms Shao-ti Liu Meredith |
---|---|
Gender | Female |
Speciality | Nurse Practitioner |
Experience | 27 Years |
Location | 8299 161st Ave Ne, Redmond, Washington |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1659353431 | NPI | - | NPPES |
9625666 | Medicaid | WA | |
ME2130 | Other | WA | BLUE SHIELD |
134472 | Other | WA | LABOR & INDUSTRIES |
500024666 | Other | WA | MEDICARE RAILROAD |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363LF0000X | Nurse Practitioner - Family | AP30005426 (Washington) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Evergreenhealth Medical Center | Kirkland, WA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
King County Public Hospital District No 2 | 7618880097 | 481 |
News Archive
Studies in animals have raised concerns that tumors may grow faster after the anticancer drug sunitinib is discontinued. But oncologists and physicists who collaborated to analyze data from the largest study of patients with kidney cancer convincingly demonstrate that such tumor acceleration does not occur in humans.
Researchers at the University of Aberdeen in Scotland, say giving daily supplements of multivitamins and minerals do not prevent respiratory, stomach, skin and other types of infections in the elderly.
Today Biogen Idec announced it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for approval of PLEGRIDY (peginterferon beta-1a), the company's pegylated subcutaneous injectable candidate for relapsing forms of multiple sclerosis (RMS).
Chinese cities are different from many Western cities in relation to urban design, and far more densely populated.
› Verified 1 days ago
Entity Name | King County Public Hospital District No 2 |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1801986070 PECOS PAC ID: 7618880097 Enrollment ID: O20031111000557 |
News Archive
Studies in animals have raised concerns that tumors may grow faster after the anticancer drug sunitinib is discontinued. But oncologists and physicists who collaborated to analyze data from the largest study of patients with kidney cancer convincingly demonstrate that such tumor acceleration does not occur in humans.
Researchers at the University of Aberdeen in Scotland, say giving daily supplements of multivitamins and minerals do not prevent respiratory, stomach, skin and other types of infections in the elderly.
Today Biogen Idec announced it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for approval of PLEGRIDY (peginterferon beta-1a), the company's pegylated subcutaneous injectable candidate for relapsing forms of multiple sclerosis (RMS).
Chinese cities are different from many Western cities in relation to urban design, and far more densely populated.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Ms Shao-ti Liu Meredith, ARNP Po Box 34036, Seattle, WA 98124-1036 Ph: (425) 899-3292 | Ms Shao-ti Liu Meredith, ARNP 8299 161st Ave Ne, Suite 101, Redmond, WA 98052-3860 Ph: (425) 881-8813 |
News Archive
Studies in animals have raised concerns that tumors may grow faster after the anticancer drug sunitinib is discontinued. But oncologists and physicists who collaborated to analyze data from the largest study of patients with kidney cancer convincingly demonstrate that such tumor acceleration does not occur in humans.
Researchers at the University of Aberdeen in Scotland, say giving daily supplements of multivitamins and minerals do not prevent respiratory, stomach, skin and other types of infections in the elderly.
Today Biogen Idec announced it has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for approval of PLEGRIDY (peginterferon beta-1a), the company's pegylated subcutaneous injectable candidate for relapsing forms of multiple sclerosis (RMS).
Chinese cities are different from many Western cities in relation to urban design, and far more densely populated.
› Verified 1 days ago
Ms. Grace Erin Oppenheim, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3925 159th Ave Ne, Redmond, WA 98052 Phone: 425-216-0550 Fax: 425-216-0551 | |
Ee Hoon Ong, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2217 152nd Ave Ne Ste 100, Redmond, WA 98052 Phone: 425-947-3563 | |
Chan Wu, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 8980 161st Ave Ne # 400, Redmond, WA 98052 Phone: 425-899-2273 | |
Katrina Mae Lapid Perez, DNP, ARNP, CPNP-PC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 22635 Ne Marketplace Dr Ste 120, Redmond, WA 98053 Phone: 425-898-7408 | |
Joan Elizabeth Pittman, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 20428 Ne 66th Ct, Redmond, WA 98053 Phone: 425-836-0801 | |
Beverly J. Karbowski, A.R.N.P. Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2700 152nd Ave Ne, Redmond, WA 98052 Phone: 425-883-5151 | |
Lorena Lisseth Salazar, DNP, PMHNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 8301 161st Ave Ne Ste 202, Redmond, WA 98052 Phone: 425-996-8592 |